文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

作者信息

Pignone Michael, Alberts Mark J, Colwell John A, Cushman Mary, Inzucchi Silvio E, Mukherjee Debabrata, Rosenson Robert S, Williams Craig D, Wilson Peter W, Kirkman M Sue

机构信息

Department of Medicine, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Circulation. 2010 Jun 22;121(24):2694-701. doi: 10.1161/CIR.0b013e3181e3b133. Epub 2010 May 27.

DOI:10.1161/CIR.0b013e3181e3b133
PMID:20508178
Abstract
摘要

相似文献

[1]
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Circulation. 2010-6-22

[2]
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.

J Vasc Nurs. 2010-12

[3]
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

Diabetes Care. 2010-6

[4]
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.

Circulation. 2007-1-2

[5]
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.

Diab Vasc Dis Res. 2012-4-16

[6]
Aspirin in the primary prevention of cardiovascular disease.

Maturitas. 2011-1

[7]
Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.

Am J Med Sci. 2011-1

[8]
Should aspirin be used for the primary prevention of cardiovascular disease in the general population?

Med Princ Pract. 2015

[9]
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

J Am Coll Cardiol. 2008-10-28

[10]
Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association: response to Skyler et al.

Diabetes Care. 2009-7

引用本文的文献

[1]
Anti-Inflammatory, Wound Healing, and Anti-Diabetic Effects of Pure Active Compounds Present in the Ryudai Gold Variety of .

Molecules. 2024-6-12

[2]
Evaluating the Efficacy and Safety of Aspirin for Primary Cardiovascular Prevention in Asian Patients with Type 2 Diabetes: A Population-Based and Propensity Score-Matched Study.

Diagnostics (Basel). 2024-6-7

[3]
Diabetic Foot Care: Assessing the Knowledge and Practices of Diabetic Patients at Aldaraga Centre, Gezira State, Sudan, 2021.

Diabetes Metab Syndr Obes. 2024-6-18

[4]
Aspirin in primary prevention of cardiovascular disease in diabetes.

Arch Med Sci Atheroscler Dis. 2021-4-22

[5]
Implications of the heterogeneity between guideline recommendations for the use of low dose aspirin in primary prevention of cardiovascular disease.

Am J Prev Cardiol. 2022-6-6

[6]
Trends in the Degree of Control and Treatment of Cardiovascular Risk Factors in People With Type 2 Diabetes in a Primary Care Setting in Catalonia During 2007-2018.

Front Endocrinol (Lausanne). 2021

[7]
Aspirin prescribing pattern and guidelines-adherence evaluation for primary prevention of cardiovascular diseases at a teaching hospital.

Saudi Pharm J. 2021-12

[8]
Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus.

BMC Cardiovasc Disord. 2020-1-13

[9]
Cost-effectiveness analysis of aspirin for primary prevention of cardiovascular events among patients with type 2 diabetes in China.

PLoS One. 2019-12-2

[10]
Aspirin for Primary Prevention of Cardiovascular Disease in Diabetes: a Review of the Evidence.

Curr Diab Rep. 2019-9-23

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索